Gratry & Company’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Gratry & Company’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-205,800	Closed	-$7.9M	–	81
2014 Q4	$7.9M	Buy	+205,800	New	+$7.27M	2.59%	22
2014 Q3	–	Sell	-81,071	Closed	-$2.66M	–	69
2014 Q2	$2.66M	Sell	81,071 -110,474	-58%	-$3.78M	1.05%	32
2014 Q1	$7.06M	Sell	191,545 -14,255	-7%	-$523K	2.54%	22
2013 Q4	$7.9M	Buy	+205,800	New	+$6.5M	2.59%	22

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Gratry & Company's WX Position: Q1 2015 in Review

Gratry & Company sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q1 2015, closing a stake of 205,800 shares — an estimated $7.9M sold.

Gratry & Company first reported a position in WX in Q4 2013 and held it in 4 quarters. The position peaked at $7.9M in Q4 2014. 147 funds tracked by Wall St. Rank hold WX as of Q1 2015.

Gratry & Company reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q1 2015 after selling out during the quarter.
Gratry & Company sold 205,800 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q1 2015, an estimated $7.9M.
Gratry & Company first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2013 and held it in 4 quarters.
Gratry & Company's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $7.9M in Q4 2014.
147 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q1 2015.

Based on Gratry & Company's 13F filing for Q1 2015, filed 13 May 2015.